Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.34 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.31 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.31 |
| ▸ | PLG | P00747 | 1/20 | 0.30 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17224027 | 0.91 | KMT2A (0.30) | CYP2A6IMPDH2KMT2A | |
| SCHEMBL29714131 | 0.86 | KMT2A (0.32) | CYP2A6IMPDH2KMT2ACCNT1CDK9 | |
| SCHEMBL21223630 | 0.85 | KDM3B (0.33) | KDM4E | |
| SCHEMBL16432349 | 0.85 | SUMO1 (0.33) | CYP2A6IMPDH2KMT2A | |
| SCHEMBL3823196 | 0.82 | DPYD (0.42) | — | |
| SCHEMBL532662 | 0.79 | DPYD (0.31) | — | |
| SCHEMBL8997737 | 0.79 | DPYD (0.31) | — | |
| SCHEMBL2827577 | 0.79 | KDM5A (0.31) | — | |
| SCHEMBL11153548 | 0.79 | — | — | |
| SCHEMBL932306 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3437 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4727953-A2 | ACCELERATED MARKING OF 5-FORMYL CYTOSINE AND USE IN NUCLEIC ACID METHYLATION SEQUENCING | F. Hoffmann-La Roche AG (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12606866-B2 | Methods for the amplification of bisulfite-treated DNA | THE UNIVERSITY OF CHICAGO (US) | 2026-04-21 | — | — | US | claimed |
| US-20260103701-A1 | TET-ASSISTED PYRIDINE BORANE SEQUENCING | EXACT SCIENCES INNOVATION LTD (GB) | 2026-04-16 | — | — | US | claimed |
| US-12601006-B2 | Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (CH) | 2026-04-14 | — | — | US | claimed |
| US-20260098287-A1 | METHOD AND KIT FOR REGENERATING REUSABLE INITIATORS FOR NUCLEIC ACID SYNTHESIS | CHENG-YAO CHEN (TW) | 2026-04-09 | — | — | US | claimed |
| EP-4713485-A2 | SEQUENCING ADAPTERS FOR METHYLATION SEQUENCING | Foundation Medicine, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| US-20140127678-A1 | Mapping Cytosine Modifications | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2014-05-08 | — | — | US | claimed |
| WO-2014071250-A1 | METHODS FOR DETECTING AND MAPPING MODIFICATIONS TO NUCLEIC ACID POLYMERS USING NANOPORE SYSTEMS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2014-05-08 | — | — | WO | claimed |
| US-20130244237-A1 | Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof and for Methylome Analysis | NEW ENGLAND BIOLABS, INC. (US) | 2013-09-19 | — | — | US | claimed |
| WO-2013138644-A2 | METHODS AND COMPOSITIONS FOR DISCRIMINATION BETWEEN CYTOSINE AND MODIFICATIONS THEREOF, AND FOR METHYLOME ANALYSIS | NEW ENGLAND BIOLABS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| WO-2013090588-A1 | METHODS AND KITS FOR DETECTION OF METHYLATION STATUS | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-06-20 | — | — | WO | claimed |
| WO-2013057202-A1 | EPIGENETIC MARKER FOR THE IDENTIFICATION OF IL17 POSITIVE T CELLS IN COMPLEX SAMPLES | EPIONTIS GMBH (DE) | 2013-04-25 | — | — | WO | claimed |
| WO-2013017853-A2 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | CAMBRIDGE EPIGENETIX LIMITED (GB) | 2013-02-07 | — | — | WO | claimed |
| US-20070161585-A1 | Immunopotentiator and method for enhancing immunoactivity using the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-07-12 | — | — | US | claimed |
| EP-1702620-A1 | IMMUNOPOTENTIATOR AND METHOD OF ENHANCING IMMUNOLOGICAL ACTIVITY WITH THE SAME | Japan Science and Technology Agency (JP) | 2006-09-20 | — | — | EP | claimed |
| WO-1993000099-A2 | USE OF PYRIMIDINE AND PURINE NUCLEOSIDES FOR THE PROPHYLAXIS AND/OR TREATMENT OF INFECTIONS CAUSED BY ADENOVIRUSES | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 1993-01-07 | — | — | WO | claimed |